These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 30451113)
1. Tetramethoxyluteolin for the Treatment of Neurodegenerative Diseases. Theoharides TC; Tsilioni I Curr Top Med Chem; 2018; 18(21):1872-1882. PubMed ID: 30451113 [TBL] [Abstract][Full Text] [Related]
3. Is a subtype of autism an allergy of the brain? Theoharides TC Clin Ther; 2013 May; 35(5):584-91. PubMed ID: 23688533 [TBL] [Abstract][Full Text] [Related]
4. Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders. Theoharides TC; Tsilioni I; Patel AB; Doyle R Transl Psychiatry; 2016 Jun; 6(6):e844. PubMed ID: 27351598 [TBL] [Abstract][Full Text] [Related]
5. Ways to Address Perinatal Mast Cell Activation and Focal Brain Inflammation, including Response to SARS-CoV-2, in Autism Spectrum Disorder. Theoharides TC J Pers Med; 2021 Aug; 11(9):. PubMed ID: 34575637 [TBL] [Abstract][Full Text] [Related]
6. IL-37 is increased in brains of children with autism spectrum disorder and inhibits human microglia stimulated by neurotensin. Tsilioni I; Patel AB; Pantazopoulos H; Berretta S; Conti P; Leeman SE; Theoharides TC Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21659-21665. PubMed ID: 31591201 [TBL] [Abstract][Full Text] [Related]
7. Dysregulated brain immunity and neurotrophin signaling in Rett syndrome and autism spectrum disorders. Theoharides TC; Athanassiou M; Panagiotidou S; Doyle R J Neuroimmunol; 2015 Feb; 279():33-8. PubMed ID: 25669997 [TBL] [Abstract][Full Text] [Related]
8. Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders? Theoharides TC; Tsilioni I; Ren H Expert Rev Clin Immunol; 2019 Jun; 15(6):639-656. PubMed ID: 30884251 [TBL] [Abstract][Full Text] [Related]
9. Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue. Theoharides TC; Cholevas C; Polyzoidis K; Politis A Biofactors; 2021 Mar; 47(2):232-241. PubMed ID: 33847020 [TBL] [Abstract][Full Text] [Related]
10. Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism. Bertolino B; Crupi R; Impellizzeri D; Bruschetta G; Cordaro M; Siracusa R; Esposito E; Cuzzocrea S CNS Neurosci Ther; 2017 Jan; 23(1):87-98. PubMed ID: 27701827 [TBL] [Abstract][Full Text] [Related]
11. Mast cells, brain inflammation and autism. Theoharides TC; Stewart JM; Panagiotidou S; Melamed I Eur J Pharmacol; 2016 May; 778():96-102. PubMed ID: 25941080 [TBL] [Abstract][Full Text] [Related]
15. Activation of Mast Cells by Neuropeptides: The Role of Pro-Inflammatory and Anti-Inflammatory Cytokines. Lauritano D; Mastrangelo F; D'Ovidio C; Ronconi G; Caraffa A; Gallenga CE; Frydas I; Kritas SK; Trimarchi M; Carinci F; Conti P Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902240 [TBL] [Abstract][Full Text] [Related]
16. Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6. Tsilioni I; Taliou A; Francis K; Theoharides TC Transl Psychiatry; 2015 Sep; 5(9):e647. PubMed ID: 26418275 [TBL] [Abstract][Full Text] [Related]
17. Mast Cells, Stress, Fear and Autism Spectrum Disorder. Theoharides TC; Kavalioti M; Tsilioni I Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31344805 [TBL] [Abstract][Full Text] [Related]